Loading...
Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: an update for the hematologist
Multiple myeloma is a common plasma cell neoplasm that is incurable with conventional therapy. The treatment paradigm of multiple myeloma is not standardized and is evolving. The advent of novel drugs, including the proteasome inhibitor bortezomib and the immunomodulatory agents, has resulted in inc...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3666447/ https://ncbi.nlm.nih.gov/pubmed/23730498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620713480155 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|